TFF3 and amyloidosis: While several of the CSF biomarkers hint at immune-mediated links between responses to amyloid deposition and brain volume loss, the function of TFF3, which we found to be the single strongest predictor of neurodegeneration across the spectrum of brain amyloidosis, is unknown.